Skip to content

The Role of CALLY and HAALP in Ulcerative Colitis

The Role of CALLY and HAALP Scores in the Evaluation of Ulcerative Colitis Attack

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07236333
Enrollment
100
Registered
2025-11-19
Start date
2020-06-01
Completion date
2025-03-31
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis (UC)

Keywords

Ulcerative Colitis, CALLY, HAALP

Brief summary

The aim of this study is to demonstrate the type and amount of retention in the colon during ulcerative colitis activation, as well as the relationship between C-reactive protein (CRP), albumin and the calculated CALLY index. The investigators also aim to establish whether this ratio can be used to indicate activation.

Interventions

DIAGNOSTIC_TESTCALLY

The CALLY index, integrating C-reactive protein (CRP), albumin, and lymphocyte count, has been identified as a promising prognostic biomarker.

DIAGNOSTIC_TESTHALP

The HALP score is calculated as HALP Score = \[hemoglobin (g/L) × albumin (g/L) × lymphocytes (/L)\]/platelets (/L). It is a definitive biomarker.

Sponsors

Akdeniz University
CollaboratorOTHER
Ataturk University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* under 18

Exclusion criteria

* no UC

Design outcomes

Primary

MeasureTime frameDescription
Change in Patients' HALP Scorethrough study completion, an average of 1 yearUlcerative colitis patients will be evaluated by evaluating the Change in HALP Score and its effect on prognosis.
Change in Patients' CALLY Index Scorethrough study completion, an average of 1 yearUlcerative colitis patients will be evaluated by evaluating the Change in CALLY Index Score and its effect on prognosis.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026